Edgewise Therapeutics Inc. (EWTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Edgewise Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$40.49
+2.43% today
Market cap
$4.3B
Overall quality
42/100
Kronos AI 30-day
−4.0%
2 of 8 simulated paths end higher
Edgewise Therapeutics Inc. (EWTX) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $4.3B. It trades at $40.49, up 2.43% today. Its overall quality score is 42 out of 100, ranked against the whole US market. 11 analysts' average target of $51.11 implies +26.2% from today's price. Kronos AI's 30-day forecast is −4.0% (2 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $51.11 |
| Low – high | $36.00 – $60.00 |
| Analysts | 11 |
| Upside to average | +26.2% |
Kronos AI 30-day forecast
| Expected close | $37.95 (−4.0%) |
| Likely range | −9.8% … +4.5% |
| As of | 2026-10-27 |
2 of 8 simulated paths end higher.
Quality scores
| Profitability | 41 |
| Solvency | 54 |
| Growth | 31 |
| Overall | 42 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.